TRU-SENTIMENT · DeltaNeutral
JNJ Trading Analysis - 09/10/2026 04:27 PM — TRU-SENTIMENT
Options chain · Stock chart · Baseline chart
JNJ (Johnson & Johnson) at $266.35. True Sentiment Bullish, delta 40-60 call 63% / put 37%, call $1,762,569 vs put $1,017,801. RSI 48.8.
- Symbol
- JNJ
- Price
- $266.35
- Article bias (separate from True Sentiment)
- bullish
- Conviction
- medium
- Published
- 2026-09-10 16:27:00 ET
- Author
- DeltaNeutral staff
TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)
True Sentiment Analysis (Delta 40-60 Options):Options flow sentiment is bullish, with a call dollar volume of $1,762,569 (63.4% of total volume).
The put-call ratio suggests investors are positioning for a potential upside in JNJ's stock price.
Key Statistics: JNJ
Fundamental Snapshot
Valuation
| P/E (Trailing) | 30.98 |
| P/E (Forward) | N/A |
| PEG Ratio | N/A |
| Price/Book | 23.00 |
Profitability
| EPS (Trailing) | $8.62 |
| EPS (Forward) | N/A |
| ROE | 24.76% |
| Net Margin | 21.48% |
Financial Health
| Revenue (TTM) | $97.93B |
| Debt/Equity | 1.37 |
| Free Cash Flow | N/A |
| Rev Growth | N/A |
Analyst Consensus
📈 Analysis
News Headlines & Context:
Recent news headlines for JNJ include:
- JNJ's talcum powder products litigation has seen significant developments, with the company facing numerous lawsuits.
- The company has been in focus due to its COVID-19 vaccine, which has been widely administered globally.
- JNJ has also been expanding its pharmaceutical pipeline with new drug approvals and acquisitions.
These headlines may impact JNJ's stock price, with potential catalysts including earnings reports, FDA approvals, and litigation outcomes.
Fundamental Analysis:
Based on the provided fundamentals data:
- Revenue: $97.93B
- Trailing EPS: $8.62
- Trailing P/E: 30.98
- Debt/Equity: 1.37
- ROE: 24.76%
JNJ's fundamentals show a strong revenue base, with a trailing P/E of 30.98, indicating a relatively fair valuation. The debt/equity ratio of 1.37 suggests a manageable debt burden. ROE of 24.76% indicates strong profitability.
Current Market Position:
Current price: $266.35
Recent price action shows a slight decline, with the stock trading near its 50-day SMA of $262.48.
Intraday momentum is neutral, with the RSI at 48.79.
Technical Analysis:
Technical Indicators
SMA trends indicate a short-term downtrend, with the 5-day SMA below the 20-day SMA. The RSI suggests neutral momentum, while the MACD shows a bullish signal.
True Sentiment Analysis (Delta 40-60 Options):
Options flow sentiment is bullish, with a call dollar volume of $1,762,569 (63.4% of total volume).
The put-call ratio suggests investors are positioning for a potential upside in JNJ's stock price.
Key Price Levels (observational only):
Key support and resistance levels are observed at $262.48 (50-day SMA) and $271.24 (5-day SMA), respectively.
25-Day Price Forecast:
JNJ is projected for $265.00 to $275.00 based on current technical trends, momentum, and indicators.
This range considers the stock's recent price action, SMA trends, RSI momentum, and MACD signals.
Defined Risk Strategy Recommendations:
Based on the price forecast, recommended strategies include:
- Bull Call Spread: Buy JNJ 261016C00270000, Sell JNJ 261016C00280000
- Iron Condor: Sell JNJ 261016P00260000, Buy JNJ 261016P00250000, Sell JNJ 261016C00270000, Buy JNJ 261016C00280000
These strategies align with the bullish sentiment and projected price range.
Risk Factors:
- Technical warning signs: Breakdown below $262.48 (50-day SMA)
- Sentiment divergences: Contrarian moves in options flow
- Volatility: ATR of 5.29
Monitoring these risk factors can help adjust the trading strategy.
Summary & Conviction Level:
Overall bias: Bullish
Conviction level: Medium
One-line trade idea: JNJ shows bullish momentum with strong institutional buying.
View JNJ Options Chain